Even Healthcare secures Khosla-led Series B at $300M target valuation
Bengaluru-based healthtech startup Even Healthcare plans a ₹208 crore Series B round, with Khosla Ventures leading. The funding values the company at approximately $300 million. The capital will support expansion in India’s growing healthtech sector.
Sources: medicaldialogues.in
“Khosla’s bet on Even underscores renewed investor appetite for India’s healthtech space, even as funding cools in other sectors—suggesting selective confidence in scalable, local models.”
Read the original reporting
The outlets below did the original reporting.
Related briefs
- IIM Sambalpur funds 9 startups as India seed winter bites
- Simple Energy’s $180M round drives India’s weekly funding surge
- Shionogi backs Celaid’s Series B, hinting at deeper biotech ties
- Celaid closes Series B second tranche, total haul undisclosed
- Investors cash out ₹25,000 crore from listed Indian startups
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.